Corundum Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.18M Buy
25,478
+140
+0.6% +$6.48K 0.52% 47
2025
Q1
$1.55M Sell
25,338
-18,196
-42% -$1.11M 0.74% 27
2024
Q4
$2.46M Buy
43,534
+17,596
+68% +$995K 0.92% 28
2024
Q3
$1.34M Sell
25,938
-2,257
-8% -$117K 0.61% 31
2024
Q2
$1.17M Buy
28,195
+17,693
+168% +$735K 0.46% 62
2024
Q1
$570K Buy
10,502
+6,084
+138% +$330K 0.27% 66
2023
Q4
$227K Sell
4,418
-3,470
-44% -$178K 0.11% 94
2023
Q3
$458K Sell
7,888
-953
-11% -$55.3K 0.26% 69
2023
Q2
$565K Sell
8,841
-6,526
-42% -$417K 0.28% 71
2023
Q1
$1.07M Buy
15,367
+7,617
+98% +$528K 0.5% 60
2022
Q4
$558K Buy
7,750
+387
+5% +$27.9K 0.32% 71
2022
Q3
$523K Buy
7,363
+423
+6% +$30K 0.33% 68
2022
Q2
$534K Sell
6,940
-1,413
-17% -$109K 0.36% 67
2022
Q1
$610K Buy
8,353
+249
+3% +$18.2K 0.57% 69
2021
Q4
$505K Buy
8,104
+866
+12% +$54K 0.33% 57
2021
Q3
$428K Buy
7,238
+861
+14% +$50.9K 0.32% 52
2021
Q2
$426K Buy
6,377
+981
+18% +$65.5K 0.28% 52
2021
Q1
$341K Buy
5,396
+319
+6% +$20.2K 0.27% 60
2020
Q4
$315K Buy
5,077
+190
+4% +$11.8K 0.26% 57
2020
Q3
$295K Buy
4,887
+459
+10% +$27.7K 0.29% 51
2020
Q2
$260K Sell
4,428
-373
-8% -$21.9K 0.31% 40
2020
Q1
$268K Sell
4,801
-540
-10% -$30.1K 0.38% 38
2019
Q4
$343K Buy
5,341
+184
+4% +$11.8K 0.36% 37
2019
Q3
$262K Sell
5,157
-3
-0.1% -$152 0.3% 46
2019
Q2
$234K Buy
5,160
+38
+0.7% +$1.72K 0.27% 51
2019
Q1
$244K Buy
+5,122
New +$244K 0.28% 44
2018
Q2
$225K Buy
4,069
+189
+5% +$10.5K 0.28% 44
2018
Q1
$245K Sell
3,880
-798
-17% -$50.4K 0.26% 38
2017
Q4
$287K Buy
4,678
+4
+0.1% +$245 0.31% 35
2017
Q3
$298 Buy
+4,674
New +$298 0.31% 31